Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study (Q30471354)
scientific article published on September 1, 1997
Language:
(P31) (Q13442814)
(P304) 936-953
(P407) (Q1860)
(P433) 5
(P478) 19
(P577) Monday, September 1, 1997
Monday, September 1, 1997
(P921) (Q12192)
(Q415167)
(P953) https://api.elsevier.com/content/article/PII:S0149291897800471?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0149291897800471?httpAccept=text/plain
(P1433) (Q15716601)
(P1476) "Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study" (language: en)
(P2093) G. R. Donowitz
M. L. Brandon
J. P. Salisbury
C. P. Harman
D. M. Tipping
A. E. Urick
G. H. Talbot
(P2860) (Q37896178)
(Q72077200)
(Q43208468)
(Q37884184)
(Q40797945)
(Q30443161)
(Q72604952)
(Q64135390)
(Q40669912)
(Q43493819)
(Q34601561)
(Q28286051)
(Q36810816)
(Q71338479)
(Q45041967)
(Q37884011)
(Q36810821)
(Q34542314)
(Q68084452)
(Q42203654)
(Q43643976)
(Q35811943)
(Q37887677)
(Q40285513)
other details
description scientific article published on September 1, 1997

External Links